The effects of atomoxetine on weight, height, and body mass index in Turkish children and adolescents with attention deficit hyperactivity disorder

References

• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington (DC): Author; 2013.
   Google Scholar
• Cheng JY, Chen RY, Ko JS, et al. Efficacy and safety of atomoxetine for attention-deficit hyperactivity disorder in children and adolescents: meta-analysis and meta-regression analysis. Psychopharmacology (Berl). 2007;194:197–209.
   PubMed Web of Science ®Google Scholar
• Greenhill LL, Newcorn JH, Gao H, et al. Effect of two different methods of initiating atomoxetine on the adverse event profile of atomoxetine. J Am Acad Child Adolesc Psychiatry. 2007;46:566–572.
   PubMed Web of Science ®Google Scholar
• Kratochvil CJ, Wernicke JF, Michelson D, et al. (2001). Long-term safety of atomoxetine in the treatment of ADHD. Presented at the 48th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Abstract number P119.
   Google Scholar
• Honolulu HI, Spencer TJ, Heiligenstein JH, et al. Result from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with ADHD. J Clin Psychiatry. 2002;63:1140–1147.
   Web of Science ®Google Scholar
• Wellman PJ. Norepinephrine and the control of food intake. Nutrition. 2000;16:837–842.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Newcorn JH, Kratochvil CJ, et al. Long-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder. J Pediatr. 2006;149:112–119.
   PubMed Web of Science ®Google Scholar
• Kratochvil CJ, Wilens TE, Greenhill LL, et al. Effects of long-term atomoxetine treatment for young children with attention deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006;45:919–927.
   PubMed Web of Science ®Google Scholar
• Neyzi O, Bundak R, Gökçay G, et al. Reference values for weight, height, head circumference, and body mass index in Turkish children. J Clin Res Pediatr Endocrinol. 2015;7:280–293. DOI:10.4274/jcrpe.2183.
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Kratochvil CJ, Sangal RB, et al. Effects of atomoxetine on growth in children with attention deficit/hyperactivity disorder following up to five years of treatment. J Child Adolesc Psychopharmacol. 2007;17:689–699.
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Newcorn JH, Kratochvil CJ, et al. Effects of atomoxetine on growth after 2-year treatment among pediatric patients with attention-deficit/hyperactivity disorder. Pediatrics. 2005;116:e74–e80.
   PubMed Web of Science ®Google Scholar
• Díez-Suárez A, Vallejo-Valdivielso M, Marín-Méndez JJ, et al. Weight, height, and body mass index in patients with attention-deficit/hyperactivity disorder treated with methylphenidate. J Child Adolesc Psychopharmacol. 2017 Oct;27(8):723–730. DOI:10.1089/cap.2016.0150. Epub 2017 Aug 17.
   PubMed Web of Science ®Google Scholar
• Kocak-Yilmaz K, Dursun OB. The effects of atomoxetine and omega 3 used for treatment of ADHD in growth, leptin, ghreline and nesfatine in rats [unpublished dissertation]. Erzurum: Ataturk University Medical Faculty; 2014.
   Google Scholar
• Donnelly C, Bangs M, Trzepacz P, et al. Safety and tolerability of atomoxetine over 3 to 4 years in children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry. 2009;48:176–185.
   PubMed Web of Science ®Google Scholar
• Ptacek R, Kuzelova H, Paclt I, et al. ADHD and growth: anthropometric changes in medicated and non-medicated ADHD boys. Med Sci Monit. 2009;15:CR595–CR599.
   Web of Science ®Google Scholar
• Durá-Travé T, Yoldi-Petri ME, Gallinas-Victoriano F, et al. Effects of osmotic-release methylphenidate on height and weight in children with attention-deficit hyperactivity disorder (ADHD) following up to four years of treatment. J Child Neurol. 2012;27:604–609.
   PubMed Web of Science ®Google Scholar
• Shaw P, Eckstrand K, Sharp W, et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci USA. 2007;104:19649–19654. DOI:10.1073/pnas.0707741104.
   PubMed Web of Science ®Google Scholar
• Berger I, Slobodin O, Aboud M, et al. Maturational delay in ADHD: evidence from CPT. Front Hum Neurosci. 2013;7:691. DOI:10.3389/fnhum.2013.00691.
   PubMed Web of Science ®Google Scholar
• Racicka E, Hanc T, Giertuga K, et al. Prevalence of overweight and obesity in children and adolescents with ADHD: the significance of comorbidities and pharmacotherapy. J Atten Disord. 2018;22:1095–1108. DOI:10.1177/1087054715578272.
   Web of Science ®Google Scholar
• Schwartz BS, Bailey-Davis L, Bandeen-Roche K, et al. Attention deficit disorder, stimulant use, and childhood body mass index trajectory. Pediatrics. 2014;133(4):668–676.
   PubMed Web of Science ®Google Scholar
• Rimmer JH, Yamaki K, Davis BM, et al. Peer reviewed: obesity and overweight prevalence among adolescents with disabilities. Prev Chronic Dis. 2011;8(2):A41.
   PubMed Web of Science ®Google Scholar
• Kweon K, Yoon JS, Park KJ, et al. Effects of atomoxetine on height and weight in Korean children and adolescents with attention-deficit/hyperactivity disorder: a retrospective chart review. Psychiatry Investig. 2018;15(6):649–654. DOI:10.30773/pi.2018.02.25.1.
   Web of Science ®Google Scholar
• Gustafsson P, Holmström E, Besjakov J, et al. ADHD symptoms and maturity – a follow-up study in school children. Acta Paediatr. 2010;99:1536–1539. DOI:10.1111/j.1651-2227.2010.01851.x.
   Web of Science ®Google Scholar
• Cortese S, Moreira-Maia CR, St Fleur D, et al. Association between ADHD and obesity: a systematic review and meta-analysis. Am J Psychiatry. 2016;173:34–43.
   PubMed Web of Science ®Google Scholar
• Biederman J, Spencer TJ, Monuteaux MC, et al. A naturalistic 10-year prospective study of height and weight in children with attention-deficit hyperactivity disorder grown up: sex and treatment effects. J Pediatr. 2010;157(4):635–640. DOI:10.1016/j.jpeds.2010.04.025.
   Web of Science ®Google Scholar
• Yoon JS, Kweon K, Park KJ, et al. Effect of atomoxetine on height and weight in Korean children and adolescents with attention-deficit/hyperactivity disorder: a retrospective chart review. J Am Acad Child Adolesc Psychiatry. 2016;55:6.37–6.39. DOI:10.1016/j.jaac.2016.09.357.
   Google Scholar
• Germinario EA, Arcieri R, Bonati M, et al. Attention-deficit/hyperactivity disorder drugs and growth: an Italian prospective observational study. J Child Adolesc Psychopharmacol. 2013;23(7):440–447.
   Web of Science ®Google Scholar